"Designing Growth Strategies is in our DNA"

Anti-obesity Drugs Market Size, Share & COVID-19 Impact Analysis, By Type (Prescription Drugs and OTC Drugs), By Distribution Channel (Hospital Pharmacy and Retail and Online Pharmacy), and Regional Forecast, 2022-2029

Region : Global | Format: PDF | Report ID: FBI104783

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Obesity - By Key Countries/Region
    2. New Product Launches
    3. Key Industry Developments – Mergers, Acquisition, and Partnerships
    4. Pipeline Analysis
    5. Impact of COVID-19 on the Global Market
  5. Global Anti-obesity Drugs Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Type
      1. Prescription Drugs
      2. OTC Drug
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail and Online Pharmacy
    3. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Anti-obesity Drugs Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Type
      1. Prescription Drugs
      2. OTC Drug
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail and Online Pharmacy
    3. Market Analysis, Insights and Forecast  – By Country
      1. U.S.
      2. Canada
  7. Europe Anti-obesity Drugs Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Type
      1. Prescription Drugs
      2. OTC Drug
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail and Online Pharmacy
    3. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Anti-obesity Drugs Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Type
      1. Prescription Drugs
      2. OTC Drug
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail and Online Pharmacy
    3. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. India
      2. China
      3. Japan
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Anti-obesity Drugs Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Type
      1. Prescription Drugs
      2. OTC Drug
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail and Online Pharmacy
    3. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Anti-obesity Drugs Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Type
      1. Prescription Drugs
      2. OTC Drug
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail and Online Pharmacy
    3. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. GCC
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2021)
    2. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. Novo Nordisk A/S
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      2. GlaxoSmithKline
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      3. Vivus Pharmaceuticals
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      4. Currax Pharmaceuticals LLC
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      5. F. Hoffmann-La Roche Ltd
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      6. Pfizer Inc.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      7. Sandoz International GmbH (Novartis AG)
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      8. Boehringer Ingelheim International GmbH
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
Read Less

Figure 01: Global Anti-obesity Drugs Market Value Share (%), By Type, 2021 & 2029

Figure 02: Global Anti-obesity Drugs Market Forecast (USD billion), by Prescription Drugs, 2018-2029

Figure 03: Global Anti-obesity Drugs Market Forecast (USD billion), by OTC Drugs, 2018-2029

Figure 04: Global Anti-obesity Drugs Market Value Share (%), By Distribution Channel, 2021 & 2029

Figure 05: Global Anti-obesity Drugs Market Forecast (USD billion), by Hospital Pharmacy, 2018-2029

Figure 06: Global Anti-obesity Drugs Market Forecast (USD billion), by Retail and Online Pharmacy, 2018-2029

Figure 07: Global Anti-obesity Drugs Market Value Share (%), By Region, 2021 & 2029

Figure 08: North America Anti-obesity Drugs Market Value (USD billion), by Type, 2021 & 2029

Figure 09: North America Anti-obesity Drugs Market Value Share (%), by Type, 2021

Figure 10: North America Anti-obesity Drugs Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 11: North America Anti-obesity Drugs Market Value Share (%), by Distribution Channel, 2021

Figure 12: North America Anti-obesity Drugs Market Value (USD billion), by Country, 2021 & 2029

Figure 13: North America Anti-obesity Drugs Market Value Share (%), by Country, 2021

Figure 14: Europe Anti-obesity Drugs Market Value (USD billion), by Type, 2021 & 2029

Figure 15: Europe Anti-obesity Drugs Market Value Share (%), by Type, 2021

Figure 16: Europe Anti-obesity Drugs Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 17: Europe Anti-obesity Drugs Market Value Share (%), by Distribution Channel, 2021

Figure 18: Europe Anti-obesity Drugs Market Value (USD billion), by Country/Sub-region, 2021 & 2029

Figure 19: Europe Anti-obesity Drugs Market Value Share (%), by Country/Sub-region, 2021

Figure 20: Asia Pacific Anti-obesity Drugs Market Value (USD billion), by Type, 2021 & 2029

Figure 21: Asia Pacific Anti-obesity Drugs Market Value Share (%), by Type, 2021

Figure 22: Asia Pacific Anti-obesity Drugs Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 23: Asia Pacific Anti-obesity Drugs Market Value Share (%), by Distribution Channel, 2021

Figure 24: Asia Pacific Anti-obesity Drugs Market Value (USD billion), by Country/Sub-region, 2021 & 2029

Figure 25: Asia Pacific Anti-obesity Drugs Market Value Share (%), by Country/Sub-region, 2021

Figure 26: Latin America Anti-obesity Drugs Market Value (USD billion), by Type, 2021 & 2029

Figure 27: Latin America Anti-obesity Drugs Market Value Share (%), by Type, 2021

Figure 28: Latin America Anti-obesity Drugs Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 29: Latin America Anti-obesity Drugs Market Value Share (%), by Distribution Channel, 2021

Figure 30: Latin America Anti-obesity Drugs Market Value (USD billion), by Country/Sub-region, 2021 & 2029

Figure 31: Latin America Anti-obesity Drugs Market Value Share (%), by Country/Sub-region, 2021

Figure 32: Middle East & Africa Anti-obesity Drugs Market Value (USD billion), by Type, 2021 & 2029

Figure 33: Middle East & Africa Anti-obesity Drugs Market Value Share (%), by Type, 2021

Figure 34: Middle East & Africa Anti-obesity Drugs Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 35: Middle East & Africa Anti-obesity Drugs Market Value Share (%), by Distribution Channel, 2021

Figure 36: Middle East & Africa Anti-obesity Drugs Market Value (USD billion), by Country/Sub-region, 2021 & 2029

Figure 37: Middle East & Africa Anti-obesity Drugs Market Value Share (%), by Country/Sub-region, 2021

Figure 38: Global Anti-obesity Drugs Market Share (%), 2021

Table 01: Global Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Type, 2018–2029

Table 02: Global Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2018–2029

Table 03: Global Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Region, 2018–2029

Table 04: North America Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Type, 2018–2029

Table 05: North America Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2018–2029

Table 06: North America Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Country, 2018–2029

Table 07: Europe Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Type, 2018–2029

Table 08: Europe Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2018–2029

Table 09: Europe Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Country/Sub-region, 2018–2029

Table 10: Asia Pacific Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Type, 2018–2029

Table 11: Asia Pacific Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2018–2029

Table 12: Asia Pacific Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Country/Sub-region, 2018–2029

Table 13: Latin America Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Type, 2018–2029

Table 14: Latin America Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2018–2029

Table 15: Latin America Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Country/Sub-region, 2018–2029

Table 16: Middle East & Africa Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Type, 2018–2029

Table 17: Middle East & Africa Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2018–2029

Table 18: Middle East & Africa Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Country/Sub-region, 2018–2029

Booklet
  • Nov, 2022
  • 2021
  • 2018-2020
  • 130

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850
    Compare Licenses Book Now

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Related Reports

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X